A detailed history of Royal Bank Of Canada transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 190,708 shares of TNDM stock, worth $6.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190,708
Previous 83,322 128.88%
Holding current value
$6.24 Million
Previous $2.95 Million 160.44%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$30.43 - $53.43 $3.27 Million - $5.74 Million
107,386 Added 128.88%
190,708 $7.68 Million
Q1 2024

May 15, 2024

BUY
$22.09 - $35.41 $329,472 - $528,140
14,915 Added 21.8%
83,322 $2.95 Million
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $538,098 - $1.17 Million
37,682 Added 122.64%
68,407 $2.02 Million
Q3 2023

Nov 14, 2023

SELL
$19.33 - $36.22 $257,359 - $482,233
-13,314 Reduced 30.23%
30,725 $638,000
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $59,748 - $104,918
2,471 Added 5.94%
44,039 $1.08 Million
Q1 2023

May 15, 2023

BUY
$35.86 - $46.5 $300,865 - $390,135
8,390 Added 25.29%
41,568 $1.69 Million
Q4 2022

Feb 14, 2023

SELL
$35.49 - $56.15 $487,029 - $770,546
-13,723 Reduced 29.26%
33,178 $1.49 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $1.19 Million - $1.88 Million
27,257 Added 138.75%
46,901 $2.25 Million
Q2 2022

Aug 15, 2022

SELL
$53.22 - $123.09 $1.1 Million - $2.56 Million
-20,758 Reduced 51.38%
19,644 $1.16 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $435,579 - $641,634
4,275 Added 11.83%
40,402 $4.7 Million
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $464,329 - $601,962
3,929 Added 12.2%
36,127 $5.44 Million
Q3 2021

Nov 15, 2021

SELL
$93.51 - $129.4 $390,123 - $539,856
-4,172 Reduced 11.47%
32,198 $3.84 Million
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $2.8 Million - $3.64 Million
36,370 New
36,370 $3.54 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.1B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.